Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of DW1125 and DW1125A for hypercholesterolemia and dyslipidemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• DW1125
• DW1125A

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Hypercholesterolemia, Dyslipidemia | Phase 3 | Status: COMPLETED